LMAT— LEMAITRE VASCULAR INC

Health Care$1.9B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net sales	$249.6M+13.5%	$219.9M+13.6%	$193.5M+19.7%	$161.7M
Cost of sales	$71.1M+3.0%	$69.0M+3.8%	$66.4M+17.1%	$56.8M
Gross profit	$178.5M+18.3%	$150.9M+18.8%	$127.0M+21.1%	$104.9M
Sales and marketing	$54.5M+16.5%	$46.7M+13.8%	$41.1M+24.7%	$32.9M
General and administrative	$42.0M+15.9%	$36.3M+13.9%	$31.8M+10.7%	$28.7M
Research and development	$14.1M-9.7%	$15.7M-7.8%	$17.0M+27.6%	$13.3M
Restructuring	$0	$0-100.0%	$485K-84.4%	$3.1M
Total operating expenses	$110.6M+12.1%	$98.6M+9.2%	$90.3M+15.7%	$78.1M
Income from operations	$67.9M+30.0%	$52.3M+42.3%	$36.7M+36.8%	$26.8M
Other income (expense):	—	—	—	—
Investment income	$13.1M+164.6%	$4.9M+60.8%	$3.1M+212.1%	$986K
Interest expense	-$5.2M-2428.8%	-$205K	—	$0
Other income (loss), net	-$638K-410.4%	-$125K+60.2%	-$314K+3.4%	-$325K
Income before income taxes	$75.2M+32.2%	$56.9M+44.1%	$39.5M+43.6%	$27.5M
Provision for income taxes	$17.4M+35.9%	$12.8M+37.0%	$9.4M+36.7%	$6.9M
Net income	$57.7M+31.1%	$44.0M+46.3%	$30.1M+45.9%	$20.6M
Basic (in dollars per share)	$2550.00+30.1%	$1960.00+44.1%	$1360.00+44.7%	$940.00
Diluted (in dollars per share)	$2520.00+30.6%	$1930.00+44.0%	$1340.00+44.1%	$930.00
Basic (in shares)	22.6M+0.8%	22.5M+1.1%	22.2M+1.1%	22.0M
Diluted (in shares)	22.9M+0.7%	22.8M+1.6%	22.4M+1.1%	22.2M
Cash dividends declared per common share (in dollars per share)	$800.00+25.0%	$640.00+14.3%	$560.00+12.0%	$500.00

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.